Cargando…
Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside
While the underlying genetic alterations and biology of acute myeloid leukemia (AML), an aggressive hematologic malignancy characterized by clonal expansion of undifferentiated myeloid cells, have been gradually unraveled in the last decades, translation into clinical treatment approaches has only j...
Autores principales: | Tesanovic, Suzana, Krenn, Peter W., Aberger, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388743/ https://www.ncbi.nlm.nih.gov/pubmed/35990601 http://dx.doi.org/10.3389/fcell.2022.944760 |
Ejemplares similares
-
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
por: Peer, Elisabeth, et al.
Publicado: (2019) -
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017) -
Gli Phosphorylation Code in Hedgehog Signal Transduction
por: Zhou, Mengmeng, et al.
Publicado: (2022) -
Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021) -
Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC‐202 blocks oncogenic hedgehog‐GLI signaling and overcomes smoothened inhibitor resistance
por: Gruber, Wolfgang, et al.
Publicado: (2017)